LIGAND PHARMACEUTICALS INC (LGND) has 7 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $3.8M. Most recent filing: Sept. 8, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 8, 2026 filed Sept. 3, 2026 | Reardon Andrew CLO & Secretary | −$1,430,434 | 5,000 | −12% | Yes | |
|
|
||||||
| Aug. 14, 2026 filed Aug. 12, 2026 | Haas Jason Director | −$292,808 | 19,414 | −100% | No | |
|
|
||||||
| Aug. 14, 2026 filed Aug. 12, 2026 | Espinoza Octavio Chief Financial Officer | $7,477,243 | 94,923 | — | Yes | |
|
|
||||||
| Aug. 4, 2026 filed Aug. 3, 2026 | Reardon Andrew CLO & Secretary | $1,183,601 | 15,000 | 0% | Yes | |
|
|
||||||
| July 6, 2026 filed June 30, 2026 | Reardon Andrew CLO & Secretary | $1,305,027 | 15,132 | +0% | Yes | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free